Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript
Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25.
Silence Therapeutics Plc (SLN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 2,014,296 | $38,271,624 | -1% | 2.31% |
| 2. | Logos Capital Arsani William | 1,476,061 | $28,045,159 | 2.27% | |
| 3. | Deep Track Capital David Kroin | 1,359,745 | $25,835,155 | -18% | 0.77% |
| 4. | Vivo Capital Albert Cha And Frank Kung | 1,105,454 | $21,003,626 | 1.94% | |
| 5. | Polar Capital Brian Ashford-Russell And Tim Woolley | 940,164 | $17,863,116 | +89% | 0.1% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,612,877 | $62,755,673 | 3.63% | |
| 2. | 3,879,173 | $54,451,046 | 0.98% | |
| 3. | 2,104,875 | $36,561,679 | 4.05% | |
| 4. | 881,173 | $15,305,975 | 0.81% | |
| 5. | 177,834 | $3,144,105 | 0% |
News See All
Silence Therapeutics plc (NASDAQ:SLN) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Silence Therapeutics 2022 Annual Results Conference Call and Webcast. Please be advised that today's conference is being recorded.
8 Medical Stocks to Buy According to Mitchell Blutt's Consonance Capital
In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt's Consonance Capital.
Is Silence Therapeutics plc (SLN) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
